{"id":"https://openalex.org/A5113239109","orcid":"https://orcid.org/0009-0007-6480-4111","observed_orcids":["https://orcid.org/0009-0007-6480-4111"],"display_name":"Paula Mu\u00f1oz Romero","raw_author_names":["P. Romero","Paula Mu\u00f1oz Romero"],"full_name":"Paula Mu\u00f1oz Romero","works_count":9,"cited_by_count":25,"summary_stats":{"2yr_mean_citedness":2.7777777777777777,"h_index":4,"i10_index":0},"ids":{"openalex":"https://openalex.org/A5113239109","orcid":"https://orcid.org/0009-0007-6480-4111","observed_orcids":["https://orcid.org/0009-0007-6480-4111"]},"affiliations":[{"institution":{"id":"https://openalex.org/I4210108499","ror":"https://ror.org/02h1wg091","display_name":"Menarini Group (Italy)","country_code":"IT","type":"company","lineage":["https://openalex.org/I4210108499"]},"years":[2026,2025,2024]}],"last_known_institutions":[{"id":"https://openalex.org/I4210108499","ror":"https://ror.org/02h1wg091","display_name":"Menarini Group (Italy)","country_code":"IT","type":"company","lineage":["https://openalex.org/I4210108499"]}],"topics":[{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","count":9,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","count":9,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","count":6,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","count":2,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10756","display_name":"Estrogen and related hormone effects","count":1,"subfield":{"id":"https://openalex.org/subfields/1310","display_name":"Endocrinology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"topic_share":[{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","value":0.0001919,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","value":4.81e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","value":3.37e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","value":1.73e-05,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10756","display_name":"Estrogen and related hormone effects","value":2.8e-06,"subfield":{"id":"https://openalex.org/subfields/1310","display_name":"Endocrinology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"x_concepts":[{"id":"2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","score":0.8299000263214111},{"id":"126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","score":0.7210000157356262},{"id":"143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","score":0.6462000012397766},{"id":"530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","score":0.6132822632789612},{"id":"121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","score":0.5835964679718018}],"counts_by_year":[{"year":2024,"works_count":1,"oa_works_count":0,"cited_by_count":2},{"year":2025,"works_count":4,"oa_works_count":1,"cited_by_count":7},{"year":2026,"works_count":4,"oa_works_count":1,"cited_by_count":16}],"display_name_alternatives":["P. Romero","Paula Mu\u00f1oz Romero"],"block_key":"p munoz romero","works_api_url":"https://api.openalex.org/works?filter=author.id:A5113239109","awards_count":0,"awards_api_url":"https://api.openalex.org/awards?filter=investigators.author.id:A5113239109","updated_date":"2026-11-13T15:08:24","created_date":"2024-06-05T00:00:00"}